Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Federal Trade Commission
Dow
Merck
QuintilesIMS
Julphar
Cipla
Moodys

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020389

« Back to Dashboard

NDA 020389 describes MYCELEX-7 COMBINATION PACK, which is a drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional details are available on the MYCELEX-7 COMBINATION PACK profile page.

The generic ingredient in MYCELEX-7 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020389
Tradename:MYCELEX-7 COMBINATION PACK
Applicant:Bayer Healthcare Llc
Ingredient:clotrimazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020389

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CREAM, TABLET;TOPICAL, VAGINALStrength1%,100MG
Approval Date:Jun 23, 1994TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
McKinsey
Farmers Insurance
Cantor Fitzgerald
Baxter
Chubb
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.